Scientists at the University of California, Riverside think they have found a fresh clue about what starts Alzheimer’s disease. Instead of the old idea that sticky plaques are the main cause, they say a tiny protein might block another protein’s job inside brain cells.
For many years, researchers focused on a protein called amyloid‑beta (Aβ). In people with Alzheimer’s, Aβ clumps together and forms plaques. This made sense because some families with early‑onset Alzheimer’s have genes that raise Aβ levels. Yet, drugs that try to erase these plaques have mostly failed.
Another protein, tau, also builds up in the brains of patients. Tau normally holds up tiny tubes called microtubules, which act like highways inside neurons, moving nutrients and signals where they’re needed.
The new study, published in Proceedings of the National Academy of Sciences, Nexus, shows that Aβ can bind to the same spots on microtubules that tau uses. When Aβ gathers inside a neuron, it can push tau out of its place.
How Aβ and Tau Compete
Researchers noticed that the part of tau that latches onto microtubules looks a lot like Aβ in size and shape. To test the idea, they glued a glowing tag onto Aβ and watched how it moved. They saw that Aβ and tau stick to microtubules with almost the same strength.
Because of this competition, a buildup of Aβ may shove tau away, breaking the microtubule highway. Without a working highway, neurons cannot ship essential supplies, and tau may start to clump and wander into wrong parts of the cell.
A Possible Trigger for Alzheimer’s
The scientists suggest that Alzheimer’s could begin when Aβ displaces tau, causing the cell’s transport system to collapse. This view flips the old picture: the plaques outside the cell might be a side effect, not the main driver.
Aging, Autophagy, and Protection
As we age, a cleaning process called autophagy slows down. Autophagy normally recycles unwanted proteins like Aβ. When it works less well, Aβ can pile up inside neurons and out‑compete tau.
Some recent work shows that lithium, a simple mineral, can help keep microtubules stable and may lower Alzheimer’s risk. This hints that protecting the microtubule highways could be a useful strategy.
What This Means for New Treatments
If future research confirms these findings, drug makers might shift focus. Instead of only trying to dissolve plaques, they could aim to stop Aβ from binding to microtubules or boost the cell’s ability to clear Aβ early.
Understanding this tug‑of‑war between Aβ and tau gives scientists a clearer picture of what goes wrong inside brain cells and points to fresh ways to fight Alzheimer’s.